Identifying dual acting small molecule inhibitors for potential treatment of castration-resistant prostate cancer
Despite application of the best available treatments, prostate cancer frequently progresses to a more advanced, drug-resistant form called metastatic castration-resistant prostate cancer.As part of our approach to the development of new treatment options we have recently identified some peptides with a novel mode of action.These peptides indirectly